Fat Loss in Patients with Metastatic Clear Cell Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors

The purpose of this study was to determine the prognostic impact of fat loss after immune checkpoint inhibitor (ICI) treatment in patients with metastatic clear cell renal cell carcinoma (ccRCC). Data from 60 patients treated with ICI therapy for metastatic ccRCC were retrospectively analyzed. Chang...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Ji Hyun, Hwang, Soohyun, Jee, ByulA, Kim, Jae-Hun, Lee, Jihwan, Chung, Jae Hoon, Song, Wan, Sung, Hyun Hwan, Jeon, Hwang Gyun, Jeong, Byong Chang, Seo, Seong Il, Jeon, Seong Soo, Lee, Hyun Moo, Park, Se Hoon, Kwon, Ghee Young, Kang, Minyong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9967473/
https://www.ncbi.nlm.nih.gov/pubmed/36835404
http://dx.doi.org/10.3390/ijms24043994

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9967473/
https://www.ncbi.nlm.nih.gov/pubmed/36835404
http://dx.doi.org/10.3390/ijms24043994

Ejemplares similares